Brief: RenovoRx Reports Full Year 2021 Financial Results
30/03/2022 13:52
March 30 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX REPORTS FULL YEAR 2021 FINANCIAL RESULTS
Source text for Eikon: ID:nBw3FzcKKa
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies